Literature DB >> 7734464

The Matrix model of outpatient stimulant abuse treatment: evidence of efficacy.

S Shoptaw1, R A Rawson, M J McCann, J L Obert.   

Abstract

The current study examined the effectiveness of Matrix outpatient stimulant treatment. We associated 146 subjects' in-treatment abstinence data, treatment lengths, and weekly treatment activities to their 6-month abstinence outcomes as part of an interim analysis of a NIDA treatment demonstration project. Results indicated that the pretreatment subject characteristics of ethnicity and drug of choice significantly associated with treatment outcome using Matrix model treatment. Findings also demonstrated a treatment dose/abstinence response such that those who received longer Matrix treatment episodes demonstrated better abstinence outcomes. Further, in-treatment abstinence status and treatment length significantly associated with drug use status at follow-up. This set of findings provides evidence for the value of Matrix treatment and allows for these outcome data to be compared with reports on recent psychosocial treatments for stimulant dependence. This study also provides direction for evaluating longer term effectiveness for these types of drug treatments.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7734464     DOI: 10.1300/j069v13n04_02

Source DB:  PubMed          Journal:  J Addict Dis        ISSN: 1055-0887


  16 in total

1.  Developing an evidence-based, multimedia group counseling curriculum toolkit.

Authors:  Adam C Brooks; Graham Diguiseppi; Alexandre Laudet; Beth Rosenwasser; Dan Knoblach; Carolyn M Carpenedo; Deni Carise; Kimberly C Kirby
Journal:  J Subst Abuse Treat       Date:  2012-02-01

2.  Comparing injection and non-injection routes of administration for heroin, methamphetamine, and cocaine users in the United States.

Authors:  Scott P Novak; Alex H Kral
Journal:  J Addict Dis       Date:  2011 Jul-Sep

3.  HIV Risk Behavior Among Methamphetamine Users Entering Substance Abuse Treatment in Cape Town, South Africa.

Authors:  Christina S Meade; Ryan R Lion; Daniella M Cordero; Melissa H Watt; John A Joska; Hetta Gouse; Warren Burnhams
Journal:  AIDS Behav       Date:  2016-10

4.  The Influence of Client Risks and Treatment Engagement on Recidivism.

Authors:  Yang Yang; Kevin Knight; George W Joe; Grace A Rowan-Szal; Wayne E K Lehman; Patrick M Flynn
Journal:  J Offender Rehabil       Date:  2013-10-28

5.  5-HT(1A)-like receptor activation inhibits abstinence-induced methamphetamine withdrawal in planarians.

Authors:  Scott M Rawls; Hardik Shah; George Ayoub; Robert B Raffa
Journal:  Neurosci Lett       Date:  2010-08-13       Impact factor: 3.046

6.  "Someone who is in this thing that I am suffering from": The role of peers and other facilitators for task sharing substance use treatment in South African HIV care.

Authors:  Jessica F Magidson; John A Joska; Kristen S Regenauer; Emily Satinsky; Lena S Andersen; C J Seitz-Brown; Christina P C Borba; Steven A Safren; Bronwyn Myers
Journal:  Int J Drug Policy       Date:  2019-05-10

7.  Beyond methamphetamine: Documenting the implementation of the Matrix model of substance use treatment for opioid users in a South African setting.

Authors:  Jessica F Magidson; Hetta Gouse; Warren Burnhams; Christie Y Y Wu; Bronwyn Myers; John A Joska; Adam W Carrico
Journal:  Addict Behav       Date:  2016-11-17       Impact factor: 3.913

8.  Process-of-care measures as predictors of client outcome among a methamphetamine-dependent sample at 12- and 36-month follow-ups.

Authors:  Richard A Rawson; Rachel Gonzales; Lisa Greenwell; Mady Chalk
Journal:  J Psychoactive Drugs       Date:  2012 Sep-Oct

9.  "That person stopped being human": Intersecting HIV and substance use stigma among patients and providers in South Africa.

Authors:  Kristen S Regenauer; Bronwyn Myers; Abigail W Batchelder; Jessica F Magidson
Journal:  Drug Alcohol Depend       Date:  2020-09-25       Impact factor: 4.492

10.  Safety of intravenous methamphetamine administration during treatment with bupropion.

Authors:  Thomas F Newton; John D Roache; Richard De La Garza; Tim Fong; Christopher L Wallace; Shou-Hua Li; Ahmed Elkashef; Nora Chiang; Roberta Kahn
Journal:  Psychopharmacology (Berl)       Date:  2005-10-19       Impact factor: 4.415

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.